Cargando…
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
Dipyridamole is an old anti-platelet and coronary vasodilator agent that inhibits platelet phosphodiesterase and increases interstitial adenosine levels. Its use in coronary artery disease (CAD) has fallen out of practice in the modern era with the advent of new anti-platelet agents, and most modern...
Autores principales: | Allahham, Mahmoud, Lerman, A., Atar, D., Birnbaum, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271326/ https://www.ncbi.nlm.nih.gov/pubmed/34245446 http://dx.doi.org/10.1007/s10557-021-07224-9 |
Ejemplares similares
-
Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin
por: Ye, Yumei, et al.
Publicado: (2011) -
Re: Dipyridamole reduces penile apoptosis in a rat model of post-prostatectomy erectile dysfunction
por: Wei, Shanzun, et al.
Publicado: (2018) -
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022) -
Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration
por: Rogosnitzky, Moshe, et al.
Publicado: (2016) -
Dipyridamole-induced STEMI: case report and review of the literature
por: Hennawi, Hussam Al, et al.
Publicado: (2023)